Disgruntled AstraZeneca sues former executive Luke Miels for jumping to GSK post
Fierce Pharma ------- Back in February, as his company’s executives were departing for posts with other biopharma players, AstraZeneca CEO Pascal Soriot called the exodus a compliment from his rivals—“very pleasing,” in fact. But when it comes to Luke Miels, the head of AZ’s European business who left to lead GlaxoSmithKline's pharma division, the British drugmaker isn’t so pleased after all. AstraZeneca is fighting Miels' departure in court, asserting breach of contract, the company said Tuesday. It has "issued proceedings seeking an order confirming that Mr. Miels is required to abide by the terms of his contract of employment," a spokeswoman said in a statement. To learn more click on the picture below to read the article.